Hester Biosciences is one of the leading animal health care companies & the second-largest poultry vaccine manufacturer in India.
The company's consolidated net profit surged 76.2% to Rs 14.45 crore on a 15.2% drop in revenue from operations to Rs 70.97 crore in Q2 FY26 over Q2 FY25.
Shares of Hester Biosciences rose 0.59% to Rs 1,672 on the BSE.
Click here to visit SEBI Scores